Kou et al. demonstrated that inonotusols H–N can inhibit LPS-induced iNOS expression and that inonotusols I and L have strong interactions with iNOS protein, which may be beneficial for the treatment of neurodegenerative diseases [43]. Here, NOS2 is linked to neurodegenerative disease.